Drug Profile
Research programme: transcription factor inhibitors - Adynxx
Alternative Names: AYX 2Latest Information Update: 23 Mar 2023
Price :
$50
*
At a glance
- Originator Adynxx
- Class Non-opioid analgesics; Oligonucleotides
- Mechanism of Action Kruppel-like transcription factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Back pain; Inflammatory pain; Neuropathic pain
Most Recent Events
- 23 Mar 2023 Discontinued - Preclinical for Back pain in USA (Parenteral)
- 23 Mar 2023 Discontinued - Preclinical for Inflammatory pain in USA (Parenteral)
- 23 Mar 2023 Discontinued - Preclinical for Neuropathic pain in USA (Parenteral)